Case ReportPublished 11 August 2026Case Report: Pancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4-RAF1 gene fusionSabrina Kammerer · Peter Bode · Heide Schreiber · Guacimara Ortega SanchezPathology and Oncology Researchdoi 10.3389/pore.2026.1612537
Case ReportPublished 22 June 2026Durable disease control after multimodal therapy and platinum-based chemotherapy rechallenge in advanced clear cell adenocarcinoma of the urethra with lymph node metastases: a case reportAkihiro Maeda · Shohei Tobu · Shuhei Kusano · Maki Kawasaki · Hiroaki Kakinoki · Mitsuru NoguchiFrontiers in Urologydoi 10.3389/fruro.2026.1865730
Case ReportPublished 23 January 2026Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphomaGuilherme Gasparini Spiandorelo · Ahmed Alnughmush · Olivia Crum · Dragan Jevremovic · J. C. VillasboasFrontiers in Hematologydoi 10.3389/frhem.2025.1683981
Original ResearchPublished 13 November 2025Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancerAlp Inci · Isabell Witzel · Holger Moch · Sepehr Rahmani-Khajouei · Martin Zoche · Eleftherios Pierre SamartzisPathology and Oncology Researchdoi 10.3389/pore.2025.1612266
